Insulin aspart - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
FIASP FLEXTOUCH insulin aspart (rys) 100 units/mL solution for injection 3 mL pre-filled pen
AUST R: 275394
Active ingredients:
Insulin aspart

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800 668 626

Deletion from market:
01 Mar 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available.
FIASP insulin aspart (rys) 100 units/mL solution for injection 10 mL vial
AUST R: 275375
Active ingredients:
Insulin aspart

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800 668 626

Deletion from market:
01 Dec 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available.
RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge
AUST R: 280432
Active ingredients:
Insulin aspart
Insulin degludec

Dosage form:
Injection, solution

Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd

Phone:
1800 668 626

Deletion from market:
01 Feb 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available.